Correlation Between Celltrion Pharm and Medy Tox

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Celltrion Pharm and Medy Tox at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Celltrion Pharm and Medy Tox into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Celltrion Pharm and Medy Tox, you can compare the effects of market volatilities on Celltrion Pharm and Medy Tox and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Celltrion Pharm with a short position of Medy Tox. Check out your portfolio center. Please also check ongoing floating volatility patterns of Celltrion Pharm and Medy Tox.

Diversification Opportunities for Celltrion Pharm and Medy Tox

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Celltrion and Medy is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Celltrion Pharm and Medy Tox in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medy Tox and Celltrion Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Celltrion Pharm are associated (or correlated) with Medy Tox. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medy Tox has no effect on the direction of Celltrion Pharm i.e., Celltrion Pharm and Medy Tox go up and down completely randomly.

Pair Corralation between Celltrion Pharm and Medy Tox

Assuming the 90 days trading horizon Celltrion Pharm is expected to under-perform the Medy Tox. But the stock apears to be less risky and, when comparing its historical volatility, Celltrion Pharm is 1.28 times less risky than Medy Tox. The stock trades about -0.27 of its potential returns per unit of risk. The Medy Tox is currently generating about -0.18 of returns per unit of risk over similar time horizon. If you would invest  12,570,000  in Medy Tox on November 7, 2024 and sell it today you would lose (730,000) from holding Medy Tox or give up 5.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy89.47%
ValuesDaily Returns

Celltrion Pharm  vs.  Medy Tox

 Performance 
       Timeline  
Celltrion Pharm 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Celltrion Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Medy Tox 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medy Tox has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Celltrion Pharm and Medy Tox Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Celltrion Pharm and Medy Tox

The main advantage of trading using opposite Celltrion Pharm and Medy Tox positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Celltrion Pharm position performs unexpectedly, Medy Tox can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medy Tox will offset losses from the drop in Medy Tox's long position.
The idea behind Celltrion Pharm and Medy Tox pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stocks Directory
Find actively traded stocks across global markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals